Botulism toxin: Use in disorders of the temporomandibular joint

Dentistry Today

Volumn 24, Issue 12, 2005, Pages 48-51

  Chang, Heera ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

BRUXISM; DYSTONIA; FACE PAIN; HUMAN; HYPERTROPHY; MASTICATORY MUSCLE; PATHOPHYSIOLOGY; REVIEW; SPASTICITY; TEMPOROMANDIBULAR JOINT DISORDER;

BOTULINUM TOXIN TYPE A; BRUXISM; DYSTONIA; FACIAL PAIN; HUMANS; HYPERTROPHY; MASTICATORY MUSCLES; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 30944461402     PISSN: 87502186     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Botox [package insert]. Irvine, Calif: Allergan Inc; 2004.
2. Daelen B, Thorwirth V, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type A botulism toxin. Int J Oral Maxillofac Surg. 1997;26:458-460.
3. Aquilina P, Vickers R, McKellar G. Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A. Br J Oral Maxillofac Surg. 2004;42:272-273.
4. Moore AP, Wood GD. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J. 1997;183:415-417.
5. Bentsianov B, Francis A, Blitzer A. Botulinum toxin treatment of temporomandibular disorders, masseteric hypertrophy, and cosmetic masseter reduction. Oper Tech Otolaryngol Head Neck Surg. 2004;15(2):110-113.
6. Park MY, Ahn KY, Jung DS. Botulism toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003;29:477-483.
7. von Lindern JJ, Niederhagen B, Berge S, et al. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003;61:774-778.
8. Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002;18(6 suppl):S198-3203.
9. Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000;38:466-471.
10. Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002;99:465-473.
11. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000;131:211-216.
12. Tan E, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999;53:2102-2107.
13. Peterson LJ, ed. Principles of Oral and Maxillofacial Surgery. 2nd ed. Hamilton, Ontario, Can: B.C. Decker; 2004:chap 48.